Patents by Inventor Hyun Ju Jeon

Hyun Ju Jeon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SNAP25 antisense oligonucleotides
    Patent number: 11261448
    Abstract: Provided are peptide nucleic acid derivatives targeting a 3? splice site of the human SNAP25 pre-mRNA. The peptide nucleic acid derivatives potently induce at least a splice variant of the human SNAP25 mRNA in cells, and are useful to safely treat dermatological indications or conditions involving the expression of the human SNAP25 protein by topical administration.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: March 1, 2022
    Assignee: OliPass Corporation
    Inventors: Daram Jung, Kangwon Jang, Bongjun Cho, Min Wook Shin, Hyun Ju Jeon, Soyoung Kim
  • SCN9A antisense pain killer
    Patent number: 11162104
    Abstract: The current invention provides peptide nucleic acid derivatives targeting the 3? splice site of exon 4 in the human SCN9A pre-mRNA. The peptide nucleic acid derivatives potently induce SCN9A mRNA splice variant(s) lacking the SCN9A exon 4 in cells, and are useful to safely treat pains or conditions involving Nav1.7 activity.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: November 2, 2021
    Assignee: OliPass Corporation
    Inventors: Shin Chung, Daram Jung, Bongjun Cho, Kangwon Jang, Hyun Ju Jeon, Jinyoung Bae, Taeyeon Bae, Yeasel Jeon, Jun Yeon Lee, Sun Hwa Park, Dan Bi An
  • SCN9A ANTISENSE PAIN KILLER
    Publication number: 20190338292
    Abstract: The current invention provides peptide nucleic acid derivatives targeting the 3? splice site of exon 4 in the human SCN9A pre-mRNA. The peptide nucleic acid derivatives potently induce SCN9A mRNA splice variant(s) lacking the SCN9A exon 4 in cells, and are useful to safely treat pains or conditions involving Nav1.7 activity.
    Type: Application
    Filed: January 23, 2018
    Publication date: November 7, 2019
    Inventors: Shin Chung, Daram Jung, Bongjun Cho, Kangwon Jang, Hyun Ju Jeon, Jinyoung Bae, Taeyeon Bae, Yeasel Jeon, Jun Yeon Lee, Sun Hwa Park, Dan Bi An
  • SNAP25 ANTISENSE OLIGONUCLEOTIDES
    Publication number: 20190338291
    Abstract: Provided are peptide nucleic acid derivatives targeting a 3? splice site of the human SNAP25 pre-mRNA. The peptide nucleic acid derivatives potently induce at least a splice variant of the human SNAP25 mRNA in cells, and are useful to safely treat dermatological indications or conditions involving the expression of the human SNAP25 protein by topical administration.
    Type: Application
    Filed: December 29, 2017
    Publication date: November 7, 2019
    Inventors: Daram Jung, Kangwon Jang, Bongjun Cho, Min Wook Shin, Hyun Ju Jeon, Soyoung Kim